azacitidine has been researched along with Cryptogenic Fibrosing Alveolitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, W; Chen, F; Chen, X; Dai, J; Gao, Q; Shi, Y; Su, X; Wei, A; Zhang, L; Zhu, X | 1 |
| Batte, K; Cantemir-Stone, CZ; Dakhlallah, D; Hitchcock, CL; Marsh, CB; Mikhail, A; Nana-Sinkam, SP; Nuovo, G; Piper, MG; Wang, Y; Wright, VP; Yan, P | 1 |
2 other study(ies) available for azacitidine and Cryptogenic Fibrosing Alveolitis
| Article | Year |
|---|---|
Inhibition of DNA methylation de-represses peroxisome proliferator-activated receptor-γ and attenuates pulmonary fibrosis.
Topics: Animals; Azacitidine; Bleomycin; DNA Methylation; Fibroblasts; Fibrosis; Humans; Idiopathic Pulmonary Fibrosis; Mice; Mice, Inbred C57BL; Mice, Knockout; PPAR gamma; Promoter Regions, Genetic | 2022 |
Epigenetic regulation of miR-17~92 contributes to the pathogenesis of pulmonary fibrosis.
Topics: Animals; Azacitidine; Cells, Cultured; Decitabine; Disease Models, Animal; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Epigenomics; Fibroblasts; Gene Expression; Humans; Idiopathic Pulmonary Fibrosis; Mice; Mice, Inbred C57BL; MicroRNAs; Real-Time Polymerase Chain Reaction; Repressor Proteins; RNA, Long Noncoding | 2013 |